Pediatric surgeons weigh AI benefits against ethical challenges and practical barriers
Artificial intelligence (AI) is rapidly advancing across modern healthcare, yet its role in pediatric surgery remains limited and ethically complex.
another news portal
Artificial intelligence (AI) is rapidly advancing across modern healthcare, yet its role in pediatric surgery remains limited and ethically complex.
Large language models (LLMs) have become crucial tools in the pursuit of artificial general intelligence (AGI).
Failed predictions are a key feature of pseudoscience, and much of my writing has documented instances of credentialed academies making bold, confident declarations, only to
This is a MedPage Today story. As President Tweety McTreason’s picks to lead federal health agencies await confirmation hearings, there are now acting directors in
Some of the lamps – which are often used for Seasonal Affective Disorder – are available to loan for up to three weeks.
Obesity is a global epidemic and a major cause of morbidity and mortality because it increases the risk for comorbidities, including heart disease and fatty
The headline reads, “Breakthrough blood test finally confirms Chronic Fatigue Syndrome.” As you might imagine, the story is far more complicated than that. Let’s start
Experts call for an urgent review of obesity treatment services amid booming demand for weight loss jabs.
But the health secretary says he will not negotiate on pay, adding that the union has lost goodwill with their five-day walkout.
People affected by rare blood clots say they feel they have been airbrushed out of the pandemic.
The rise of these treatments has major implications for how we think about obesity, says James Gallagher.
Even a low daily intake of alcohol–just 9 g or around one standard drink-is linked to a 50% heightened risk of mouth (buccal mucosa) cancer
For over a century, Alzheimer’s disease (AD) has been considered irreversible. Consequently, research has focused on disease prevention or slowing, rather than recovery.
A team led by investigators at Mass General Brigham and Dana-Farber Cancer Institute has developed and validated an artificial intelligence (AI)–based noninvasive tool that can